Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410300 · ClinicalTrials.gov registry record
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
A clinical trial of Lung Cancer, sponsored by Bo Lu.
- Recruiting
- Registry status
- 125
- Enrollment target
- 3
- Study locations
NCT06410300: Recruiting study of Lung Cancer, sponsored by Bo Lu.
NCT06410300 is a study of Lung Cancer that is actively recruiting participants, run by Bo Lu. The registered enrollment target is 125 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06410300, a study of Lung Cancer, is actively recruiting participants, sponsored by Bo Lu.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of this study is to evaluate cardiopulmonary toxicity in patients with lung cancer (NSCLC or SCLC) undergoing combined thoracic radiotherapy ± chemotherapy and immunotherapy through timed monitoring and blood sample collection and to identify correlative biomarkers for predicting cardiopulmonary adverse events.
Conditions Studied
Interventions
- DRUG Immunotherapy
- RADIATION Curative Radiotherapy
Study Locations (3)
Missouri
- University of Missouri - Ellis Fischel Cancer Center - Columbia
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-04-19 |
| Est. Completion | 2030-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06410300
The ClinicalTrials.gov registry entry for NCT06410300 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Bo Lu, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Immunotherapy is the first listed.
NCT06410300 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Missouri, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06410300 about?
NCT06410300 is a clinical study titled "Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy". The overall purpose of this study is to evaluate cardiopulmonary toxicity in patients with lung cancer (NSCLC or SCLC) undergoing combined thoracic radiotherapy ± chemotherapy and immunotherapy through timed monitoring and blood sample collection and to identify correlative biomarkers for predicting...
What is the current status of trial NCT06410300?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2024-04-19. Estimated completion is 2030-04-19.
What conditions does trial NCT06410300 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06410300?
The interventions under investigation include: Immunotherapy (DRUG), Curative Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT06410300?
This trial is sponsored by Bo Lu, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06410300 being conducted?
This trial has 3 study locations across Missouri, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.